Health plans go beyond the clinical setting to address housing insecurity A safeRead more
Drug Pricing
Securing Affordable Treatments for All Americans
Left unchecked, the pharmaceutical industry continues to set exorbitant drug prices and hinder competition in the marketplace. ACHP advocates for policies that promote reasonable prescription drug prices and ensure a sustainable health care system that works for patients and health plans alike. ACHP is dedicated to cracking down on anticompetitive practices, spurring development of generic and biosimilar treatments and increasing transparency around price setting.
To the Point
-
03/05/2020
OP-ED — We Must Win the War on Drug Pricing if We Want to Win the War on Cancer
We may be winning battles against cancer. But we will lose the war if we don’t do something about the rising cost of drugs in the United States. -
03/06/2020
FACT SHEET — Support Legislation to Reduce Drug Prices
Legislation can help check drug makers ability to hike prices and inject more competition into the market — helping lower prices for all. -
04/08/2019
INFOGRAPHIC — A Unique Approach: Transparent PBMs
ACHP member health plans run fully transparent, fee-based PBMs that keep drug costs in check. -
10/05/2018
INFOGRAPHIC — Biosimilars: An Antidote For High Prices
Millions struggle to pay high drug prices, forcing them to choose either medication or other expenses. Our infographic explains how “biosimilars” can help.
Deep Dive
-
04/07/2020
LETTER — Medicare Part C-D Regulations, 2020
ACHP's comments in response to the proposed rule on Medicare Advantage and Part D for the Contract Year 2021 and 2022. -
12/17/2019
RELEASE — ACHP statement on House passage of 2020 appropriations legislation
Passing the bipartisan CREATES Act is a key step in discouraging anticompetitive behavior, removing barriers to competition for generics and providing consumers relief.
